The Genetics of Alzheimer Disease
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Family history is the second strongest risk factor for Alzheimer disease (AD) following advanced age.Twin and family studies indicate that genetic factors are estimated to play a role in at least 80% of AD cases.The inheritance of AD exhibits a dichotomous pattern.On one hand, rare mutations in APP, PSEN1, and PSEN2 virtually guarantee early-onset (,60 years) familial AD, which represents 5% of AD.On the other hand, common gene polymorphisms, such as the 14 and 12 variants of the APOE gene, can influence susceptibility for 50% of the common late-onset AD.These four genes account for 30% -50% of the inheritability of AD.Genome-wide association studies have recently led to the identification of 11 additional AD candidate genes.This paper reviews the past, present, and future attempts to elucidate the complex and heterogeneous genetic underpinnings of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“To date, 228 PSEN1 mutations have been identified causing ADAD (49, 303, 304, 440, 566, 580).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [580]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“CLU gene encodes clusterin or APOJ that besides its functions in lipid transport, membrane recycling, cell adhesion, and apoptosis (90, 444, 600, 677) affects transvascular A 𝛃 clearance by promoting A 𝛃 42 efflux across the BBB (580).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [580]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PSEN1 mutations lead to faster soluble-to-fibrillar conversion of A 𝛃 42 promoting amyloid deposition in the brain (303, 566, 580).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [580]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Autosomal-dominant AD (ADAD) is an inherited form of AD caused by mutations in amyloid precursor protein ( APP ) and presenilin-1 and 2 ( PSEN1; PSEN2 ) genes (49, 177, 303, 304, 580).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [580]
The cited source says what the claim attributes to it.
In the citing paper
“APOE4 is the major genetic risk factor for sporadic, late-onset AD (199, 368, 580, 612).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [580]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Finding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 3×
“Goate et al. (1991), then resequenced the same two APP exons to reveal the first EO-FAD mutation (London mutation; V717I) in APP.”
BackgroundThe precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619 · cited 1×
“In 1987, we as well as others isolated the amyloid b (A4) protein precursor (APP; Goldgaber et al. 1987; Kang et al. 1987; Tanzi et al. 1987a, 1988) and mapped it to chromosome 21.”
BackgroundCloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051 · cited 3×
“1987b); they were ultimately demonstrated to carry PSEN1 mutations (Sherrington et al. 1995).”
BackgroundSelf-citationHarold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326 · cited 14×
“Genetic association studies remain the most common method for identifying novel LOAD genes and are most often employed in the form of large-scale GWASs that screen the entire human genome for novel disease loci.”
InfluentialScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599 · cited 3×
“Whether EO-FAD mutations appear in APP near the g-secretase cleavage site or in the presenilins, the vast majority of them serve to increase the ratio of Ab42:Ab40. g-Secretase modulators are aimed at reversing this ratio and represent very promising compounds for treating and preventing AD based on what has been garn…”
BackgroundSelf-citationCandidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577 · cited 1×
“Shortly thereafter, we first reported a homolog of PSEN1 called presenilin (PSEN2; Levy-Lahad et al. 1995) on chromosome 1 and showed that it harbors the N141I mutation in Volga-German EO-FAD families.”
BackgroundSelf-citationGenome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
Research works printed but not linked: 2
- Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, Zis- mann VL, Joshipura KD, Pearson JV, Hu-Lince D, Huen- telman MJ, et al. 2007. Papassotiropoulos A, Stephan DA. GAB2 alleles modify Alzheimer's risk in APOE 14 car- riers. Neuron 54: 713 -720.
- Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. 1993. Apolipopro- tein E: High-avidity binding to b-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci 90: 1977-1981.
Cited by
Items 601–700 of 804
VTA-forebrain connectivity moderates adaptive behavior
Sinza, S. I., Choi, K., Lim, I. E., Williams, M. A., & Ogundele, O. M. (2026) · Brain Structure and Function · doi:10.1007/s00429-026-03071-2 · Cited by 2
Uzoechi, S. C., Johnson-Campbell, C., Badeaux, C. J., Kwak, S. S., Kim, D. Y., & Yun, Y. (2026) · Molecular Brain · doi:10.1186/s13041-026-01285-3 · Cited by 2
Reduced CB1 Cannabinoid Receptor Expression in Alzheimer's Disease and Transgenic Mouse Models
von Borcke, N., Purwien, A. V., Steiert, A., Hasecke, H., & Bouter, Y. (2026) · Aging Medicine · doi:10.1002/agm2.70080 · Cited by 3
Unhealthy dietary patterns and Alzheimer’s disease: associations and underlying mechanistic pathways
Ramasinghe, C., & Xu, B. (2026) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2026.2691237 · Cited by 2
Alzheimer’s Disease: A Thermodynamic Perspective
Lucia, U., Grisolia, G., & Deisboeck, T. S. (2020) · Applied Sciences · doi:10.3390/app10217562 · Cited by 3
Shumail, H., Khalid, S., Alqahtani, T., Al‐Gahtany, M., Din, M. A. U., & Alqahtani, A. (2021) · Main Group Chemistry · doi:10.3233/mgc-210075 · Cited by 2
Coad, B. M., Ghomroudi, P. A., Sims, R., Aggleton, J. P., Vann, S. D., & Metzler‐Baddeley, C. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.02.004 · Cited by 2
Aging, Dementia, and Alzheimer Disease
Sontheimer, H. W. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821228-8.00004-4 · Cited by 2
Impact of sex and APOE-ε4 genotype on regional brain metabolism in Alzheimer's Disease
Sauty, B., & Durrleman, S. (2023) · IEEE International Symposium on Biomedical Imaging (ISBI) · doi:10.1109/isbi53787.2023.10230777 · Cited by 4
Zanwar, A. A., Joshi, A., Gaikwad, P. S., & Hegde, M. V. (2024) · Chronicle of Diabetes Research and Practice · doi:10.4103/cdrp.cdrp_17_23 · Cited by 2
Biomarker utility in Alzheimer's disease clinical trials
Soares, H. D., & Lovestone, S. (2013) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2013.09.002 · Cited by 2
Neurodegenerative Diseases and Dementia
Janus, C., & Welzl, H. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3777-6_6 · Cited by 2
Epigenetic basis of neuronal plasticity: Association with R/G-band boundaries on human chromosomes
Watanabe, Y., & Maekawa, M. (2016) · Neuroepigenetics · doi:10.1016/j.nepig.2016.08.001 · Cited by 2
Jiang, B., Zhang, X., Chen, M., Wang, Z., Zhao, M.-X., Chen, B.-H., & Li, H. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s150283 · Cited by 2
Neuroinflammation in Age-Related Neurodegenerative Diseases
MacPherson, K. P., Rodrigues, M. E. D. S., Cintron, A. F., & Tansey, M. G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00016-x · Cited by 3
Stoychev, K., Stoimenova-Popova, M. Y., Chumpalova, P. G., Ilieva, L., Swamad, M., & Kamburova-Martinova, Z. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00857 · Cited by 2
Dalmagro, A. P., Cazarin, C. A., & Zenaide, F. D. S. (2020) · Brazilian Applied Science Review · doi:10.34115/basrv4n1-008 · Cited by 14
Gene polymorphisms and their role in autoimmunity
Jan, H., Arafah, A. M., Alsuwayni, B. M., Hussein, I. M., Alhossan, A., Ali, S., & Rehman, M. U. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90053-9.00009-9 · Cited by 4
Functional data classification using the rotation forest method combined with the patch selection
Chang, J. (2023) · Communications in Statistics - Simulation and Computation · doi:10.1080/03610918.2023.2205619 · Cited by 2
γ-Secretase As a Drug Target for Familial Alzheimer's Disease: The Road Less Traveled
Wolfe, M. S. (2022) · Future Medicinal Chemistry · doi:10.4155/fmc-2022-0178 · Cited by 2
Next Generation Sequencing in Neurology and Psychiatry
Szymańska, K., Szczałuba, K., Kostera‐Pruszczyk, A., & Wolańczyk, T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801739-5.00006-4 · Cited by 1
Advances in Deep Learning for the Detection of Alzheimer’s Disease Using MRI—A Review
Hariharan, S., & Agarwal, R. (2024) · Studies in computational intelligence · doi:10.1007/978-981-99-8853-2_22 · Cited by 1
Ivanov, M. V., Kopeykina, A. S., Kazakova, E. M., Tarasova, I. A., Sun, Z., Postoenko, V. I., Yang, J.-H., & Gorshkov, M. V. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00677 · Cited by 1
Zhao, S., Yang, Q., & Gao, C. (2025) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.24000246 · Cited by 1
Grueneberg Ganglion: An Unexplored Site for Intranasal Drug Delivery in Alzheimer’s Disease
Kakoty, V., Kang, J. H., Lee, O. H., Oh, D. H., & Ko, Y. T. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00376 · Cited by 1
Nutrients and Drugs in Alzheimer’s Disease: Harnessing Antioxidants
Shteinberg, M., Nissim, T., Zaken, K. B., Sawaid, I. O., Segev, L., Mesfin, S., Frankel, P., Ezzy, R., Saha, T., Bloch, N., et al. (2025) · International journal of Nutrition Pharmacology Neurological Diseases · doi:10.4103/ijnpnd.ijnpnd_123_25 · Cited by 1
APOE isoform‐associated tau oligomer polymorphs differ in synaptotoxicity and seeding activity
Moreno, N., Shchankin, N., Fung, L., Puangmalai, N., Bhatt, N. N., Haque, M. A., Zhao, Y., Keene, C. D., Limón, A., & Kayed, R. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70965 · Cited by 2
Sharma, S., Rawat, E., Sharma, P., & Kapoor, D. U. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00231-2 · Cited by 1
Mukherjee, K., & Bhattacharyya, S. N. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1708031 · Cited by 1
Dondi, M., Bianchi, E., Borghetti, P., Lecce, R. D., Gnudi, G., Guarnieri, C., Buffagni, V., Ravanetti, F., Saleri, R., & Corradi, A. (2026) · Veterinary Sciences · doi:10.3390/vetsci13030298 · Cited by 2
Belavadi, S., & Kadiri, S. K. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178913 · Cited by 1
Jaberi, K. R., Alashti, S. K., Hooshmandi, S., Vatankhah, P., Haghighi, M. R., Savardashtaki, A., Aligholi, H., & Jaberi, A. R. (2026) · Journal of Medical Signals & Sensors · doi:10.4103/jmss.jmss_70_25 · Cited by 1
Karan, K. R., Hackett, N. R., & Crystal, R. G. (2026) · Human Gene Therapy · doi:10.1177/10430342261473427 · Cited by 1
Genetic Risk Factors for Alzheimer’s Disease
Combarros, O. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6380-0_4 · Cited by 1
Degenerative Brain Diseases and White Matter Injury
Bartzokis, G., & Lu, P. H. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9123-1_14 · Cited by 1
Pietropaolo, S., Sluyter, F., & Crusio, W. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.030 · Cited by 1
Apolipoprotein E4: A Risk Factor for Successful Cognitive Aging
Kwon, O. D. (2016) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2016.15.3.61 · Cited by 1
Epigenetics in Brain Development and Disease
Radford, E. J., Ferguson‐Smith, A. C., & Ferrón, S. R. (2017) · Wiley eBooks · doi:10.1002/9781118540770.ch14 · Cited by 1
The Effect of Silver Nanoparticles on the Scavenger Receptor-Scara1 on Microglia
Sikorska, K., Grądzka, I., & Wasyk, I. (2017) · Proceedings of the World Congress on Recent Advances in Nanotechnology · doi:10.11159/icnb17.115 · Cited by 1
Partial Identification of Amyloid-β Degrading Activity in Human Serum.
Mikawa, R., Okuno, A., Yoshimi, T., Watanabe, A., Maruyama, M., & Takikawa, O. (2019) · PubMed Central · doi:10.18999/nagjms.81.1.55 · Cited by 1
Pharmacogenomics and Personalized Medicine in Alzheimer’s Disease
Archer, T., & Johansson, B. E. A. (2013) · Springer eBooks · doi:10.1007/978-81-322-1184-6_15 · Cited by 1
Goldman, J. S. (2014) · Springer eBooks · doi:10.1007/978-1-4899-7482-2_7 · Cited by 1
Ikonomović, M. D., & DeKosky, S. T. (2014) · Springer eBooks · doi:10.1007/978-3-7091-0715-7_7 · Cited by 1
Cerebral hemorrhages in traumatic brain injury
Irimia, A., Rostowsky, K. A., Law, E. M., & Chui, H. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823347-4.00030-0 · Cited by 1
Emerging Treatments for Alzheimer's Disease
Zhao, Z. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v54i.9778 · Cited by 2
Neurobiosensors: novel approaches towards early diagnostics of neurodegenerative disorders
Parihar, A., Sharma, P., Choudhary, N. K., & Khan, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95539-3.00007-7 · Cited by 2
Şahin, K., & Rüstemoğlu, A. (2023) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2023.2253282 · Cited by 1
Familiar Strangers in the Shrouded Forest: Stigma, Representation and Alzheimer’s Disease in Always
Young, A. P. (2023) · Humanities · doi:10.3390/h12050121 · Cited by 1
Potential Stem Cell Treatment for Alzheimer’s Disease with Possible Applications of Lithium Therapy
Caputo, T. J., Inayat, M. S., & Gallicchio, V. S. (2024) · Journal of Clinical and Laboratory Medicine · doi:10.16966/2572-9578.142 · Cited by 1
Recent advances in neurodegenerative disease research
Singh, E., & Dilawari, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28822-7.00014-3 · Cited by 1
Zahid, A., Sajjad, S., Chaudhry, R. S., Batool, F., & Adil, T. (2025) · journal of social sciences review · doi:10.62843/jssr.v5i1.495 · Cited by 2
Gene Therapy for Neurological Disease
Friedmann, T. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410529-4.00008-5 · Cited by 1
A human embryonic stem cell model of Aβ-dependent chronic progressive neurodegenerationPreprint
Ubina, T., Magallanes, M., Srivastava, S., Warden, C., Yee, J., & Salvaterra, P. M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/419978 · Cited by 1
Wickstead, E. S. (2019) · WestminsterResearch (University of Westminster) · doi:10.34737/qy292 · Cited by 1
Lipids in Neurodegenerative Diseases
Yost, H., Patel, R., Kipp, A., & Reed, T. T. (2020) · Wiley eBooks · doi:10.1002/047167849x.bio115 · Cited by 1
Bouranis, N. (2020) · doi:10.15760/etd.7337 · Cited by 2
Vieira, R. N., Magalhães, J. D., Sant’Anna, J., Moriguti, M. M., de Miranda, D. M., Marco, L. A. D., de Moraes, E. N., Romano‐Silva, M. A., Bicalho, M. A. C., de Paula, J. J., et al. (2015) · International Psychogeriatrics · doi:10.1017/s1041610215001040 · Cited by 1
Sarma, M., & Chatterjee, S. (2024) · Preprints.org · doi:10.20944/preprints202408.2231.v1 · Cited by 1
Elucidating the Pathophysiological Mechanisms of Alzheimer’s DiseasePreprint
Saragea, P. D. (2024) · Preprints.org · doi:10.20944/preprints202409.0687.v1 · Cited by 1
Adeola, H. A., & Robinson, R. A. S. (2025) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.5c00074 · Cited by 1
Shared Genetic Architecture Between Kidney Function and Alzheimer Disease Across AncestriesPreprint
Yang, D., Yang, Y., Ray, N. R., Li, M., Benchek, P. H., Crawford, D. C., O’Toole, J. F., Sedor, J. R., Reitz, C., Lynn, A., et al. (2026) · medRxiv · doi:10.64898/2026.04.04.26350158 · Cited by 1
Abazid, M. (2022) · theses.fr (ABES) · doi:10.70675/7ee63a32z36e9z467fzb33fzac28590ebd0f · Cited by 3
Epigenomic Biomarkers for the Advance of Personalized Medicine
Méndez‐González, J., & Sandoval, J. (2015) · Translational bioinformatics · doi:10.1007/978-94-017-9927-0_9
Adwan, L. I. (2013) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-adwan-lina-2013
Prion protein gene in Alzheimer's disease
Caramelli, P. (2013) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20130093
Genetic approaches to neurodegenerative disease
Takada, L. T. (2016) · Cambridge University Press eBooks · doi:10.1017/9781139924771.006 · Cited by 1
Wilken, P. (2017) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6030
Neuron-to-neuron propagation of neurodegenerative proteins; relation to degradative systems
Domert, J. (2017) · Linköping University medical dissertations · doi:10.3384/diss.diva-134667
Gomes, S. M. (2017) · TSpace (University of Toronto)
NUCLEAR RECEPTORS AS THERAPEUTIC TARGETS FOR ALZHEIMER’S DISEASE
Courtney, R. (2017) · OhioLink ETD Center (Ohio Library and Information Network)
A venture into the epigenetics of aging and Alzheimer’s Disease
Lardenoije (2017) · Research Publications (Maastricht University) · doi:10.26481/dis.20170907rl · Cited by 2
Shah, N., Dogar, M. U., Shah, P. N., Ishtiaq, S., Mathew, S. S., Shah, P., Ishtiaq, A., & Vittorio, T. J. (2018) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944718756563
Reinert, J. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6699
Apolipoprotein e4 influences on scene representation in young adults
Cavill, R. (2017) · ORCA Online Research @Cardiff (Cardiff University)
Zumkehr, J. (2017) · eScholarship (California Digital Library)
Analyse neurodegenerativer Prozesse im Gyrus Dentatus im Tg4-42-Mausmodell der Alzheimerdemenz
Schubert, N. L. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6811
El polimorfismo humano ARG72PRO de Tp53 condiciona a la susceptibilidad neuronal a B-Amiloide
de Gauna, R. L. R. (2016) · Gredos (University of Salamanca) · doi:10.14201/gredos.132968 · Cited by 1
The role of GPR55 in neuronal and immune cell signalling and function
Haugh, O. (2019) · Arrow@dit (Dublin Institute of Technology)
Knudsen, K. J. (2019) · HARVEST (University of Saskatchewan)
Identification of the modulators of and the molecular pathways involved in the BIN1-Tau interaction
Mendes, T. (2018) · theses.fr (ABES) · doi:10.70675/7f8b5d9cz1433z4dd0za940zdc3273d248b0
Interaction entre l’âge et la concentration de DHA dans le plasma sur les fonctions cognitives
Houeto, A. (2019) · Knowledge UdeS (Institutional Deposit of the University of Sherbrooke)
Levels of Analysis in Alzheimer’s Disease Research
Heckers, S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108750349.038
Genetic and functional studies of genes involved in the pathogenesis of Alzheimer's disease
Natunen, T. (2014) · UEF eRepo (University of Eastern Finland)
Tan, Z. X., Benkert, H., Bhatia, S., Mirza-Davies, A., Harrison, J. R., Tax, C. M. W., & Jones, D. K. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.09.562
The Neuropeptide Kyotorphin as a Possible Biomarker and Neuroprotective Agent in Alzheimer’s Disease
Angelova, H., Pechlivanova, D., Landzhov, B. V., & Dzhambazova, E. B. (2020) · Journal of Biomedical and Clinical Research · doi:10.2478/jbcr-2020-0002
APPLYING DEEP LEARNING METHODS TO THE AI EXPERT SYSTEM ON ALZHEIMER`S DISEASE FOR THE ELDERLY
Chang, C.-Y., Wu, Y.-H., Hong, W., & Lin, C.-H. C. A. Y.-C. (2020) · IADIS International Conference on e-Health (EH) · doi:10.33965/eh2020_202009l022
Szymanski, J. P. (2021) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · Cited by 1
Peripheral Expression Levels of Selected Oxidative Stress-Related Genes in Alzheimer’s Disease
Köseoğlu, P. K., Güven, G., Lohmann, E., Hanağası, H., Gürvit, İ., Bılgıç, B., Diker, I. Y., & Erginel‐Ünaltuna, N. (2021) · Experimed · doi:10.26650/experimed.2021.911956
Mechanism of tripeptide trimming by γ-secretase
Bhattarai, A., Devkota, S., Do, H. N., Wang, J., Bhattarai, S., Wolfe, M. S., & Miao, Y. (2022) · Biophysical Journal · doi:10.1016/j.bpj.2021.11.2298
Carrasquillo, M. M., Bu, G., & Nielsen, H. M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7309-1_2
Zampar, S. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9004
Hussein, M. A., El-Laban, N. M., Elabody, L. H., Ghazal, A. M., Mohamed, B. S., Mohamed, A. A., Elhalafwy, L. Y., Elsayad, S. M., Othman, A. S., & Ali, A. (2021) · Acta Scientifci Nutritional Health · doi:10.31080/asnh.2020.05.0889 · Cited by 1
Camins, A., & Ettcheto, M. (2022) · Current Pharmaceutical Design · doi:10.2174/138161282814220713113802
Gene-expression control in early and late-onset dementia
Zhou, J. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9465
Functioning and Disability in Alzheimer’s Disease
Castillo-Mariqueo, L. (2022) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2022.44.007114
Metadata
- Authors
- Tanzi, R. E.
- Affiliations
- Harvard University (US)
- Corresponding author
- Tanzi, R. E.
- ORCID
- Tanzi, R. E.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2012-07-25
- Volume
- 2
- Issue
- 10
- Pages
- a006296-a006296
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W4233829850
- Cited by
- 727
- References
- 55
- Citations by year
- 2026: 40 · 2025: 55 · 2024: 58 · 2023: 70 · 2022: 54 · 2021: 49 · 2020: 54 · 2019: 40 · 2018: 42 · 2017: 55 · 2016: 60 · 2015: 52 · 2014: 61 · 2013: 32 · 2012: 5
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Medicine (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- Alzheimer's disease, genetic susceptibility, familial Alzheimer's disease, APP mutations, presenilin 1, presenilin 2, apolipoprotein E, APOE ε4, late-onset Alzheimer's disease, twin and family studies, genome-wide association study, candidate genes, heritability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.